Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc.（GLSI）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · GLSI · 截至 2026年6月9日
活动摘要
买入笔数
17
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Greenwich LifeSciences, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
GLSI 季度内部人买卖趋势
GLSI 内幕交易卖出 · GLSI 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · GLSI CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
GLSI 高管卖出股份 · GLSI 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jan 13, 2026 | Patel Snehal CEO and CFO · Director | Purchase | 1,800 | $54K | Form 4 |
| Jan 12, 2026 | Patel Snehal CEO and CFO · Director | Purchase | 2,900 | $80K | Form 4 |
| Dec 31, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 4,300 | $92K | Form 4 |
| Dec 30, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 2,900 | $63K | Form 4 |
| Dec 18, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 4,100 | $52K | Form 4 |
| Nov 25, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 4,600 | $39K | Form 4 |
| Nov 7, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 10,600 | $89K | Form 4 |
| Oct 31, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 2,300 | $21K | Form 4 |
| Apr 25, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 3,600 | $36K | Form 4 |
| Apr 17, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 5,400 | $48K | Form 4 |
| Apr 7, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 3,600 | $33K | Form 4 |
| Apr 4, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 5,500 | $48K | Form 4 |
| Jan 10, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 2,500 | $31K | Form 4 |
| Jan 7, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 1,800 | $25K | Form 4 |
| Jan 6, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 1,100 | $15K | Form 4 |
| Jan 3, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 3,400 | $44K | Form 4 |
| Jan 2, 2025 | Patel Snehal CEO and CFO · Director | Purchase | 2,000 | $24K | Form 4 |
| Dec 31, 2024 | Patel Snehal CEO and CFO · Director | Purchase | 2,400 | $27K | Form 4 |
| Dec 30, 2024 | Patel Snehal CEO and CFO · Director | Purchase | 3,200 | $36K | Form 4 |
| Nov 21, 2024 | Thompson Jaye VP Clinical Reg Affairs | Purchase | 1,000 | $13K | Form 4 |
| Sep 26, 2024 | Patel Snehal CEO and CFO · Director | Purchase | 1,500 | $22K | Form 4 |
| Aug 12, 2024 | Thompson Jaye VP Clinical Reg Affairs | Purchase | 800 | $11K | Form 4 |
| Aug 6, 2024 | Patel Snehal CEO and CFO · Director | Purchase | 2,000 | $28K | Form 4 |
| Aug 5, 2024 | Patel Snehal CEO and CFO · Director | Purchase | 5,500 | $72K | Form 4 |
| Aug 2, 2024 | Thompson Jaye VP Clinical Reg Affairs | Purchase | 1,000 | $15K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 GLSI 内幕交易
GLSI 内幕交易
Greenwich LifeSciences, Inc.（GLSI）内幕交易数据来源于公司内部人（包括Patel Snehal (CEO and CFO · Director)）提交的SEC Form 4申报文件。过去12个月内，1位内部人向SEC提交了交易申报。GLSI内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Greenwich LifeSciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
GLSI 内幕交易 · 5个问题Greenwich LifeSciences, Inc.（GLSI）的内部人包括高管和董事，如Patel Snehal (CEO and CFO · Director)等。过去12个月内，1位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026